In-vitro diagnostics, laboratory testing plays a crucial role in medical decision making. COVID-19 highlighted how important diagnostics can be in managing this devastating disease. Despite the pandemic, the industry is going through a transformation. Diagnostic tests are getting more complex and personalized, digital solutions challenge the status quo, clinical evidence requirements are increasing, and regulators, payers scrutinize new product approvals even sharper.

The Diagnostics Reimbursement Compass introduces a framework on how can novel diagnostics define, demonstrate and capture value. In the book you will discover:

If you work on launching new innovative, in-vitro diagnostic solutions and would like to have a brief overview on how to achieve reimbursement, this 90-minute guide will provide you a holistic framework with some relevant, specific examples, mostly from European countries.